Eli Lilly prices USD 9B multi-tranche notes offering

• Eli Lilly completed a USD 9.0 billion multi-tranche debt offering of Floating Rate Notes due 2028 and 2029, fixed-rate notes due 2029, 2031, 2033, 2036, 2056, and 2066.
• Net proceeds were about USD 8.94 billion.
• The floating-rate tranches reset quarterly at Compounded SOFR + 0.35% for the 2028 notes, Compounded SOFR + 0.46% for the 2029 notes.
• The fixed-rate tranches carry coupons ranging from 4.15% to 5.7%.
• Several 2029-2036 notes are subject to a special mandatory redemption at 101% of principal if the Centessa acquisition is not completed by the outside date.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eli Lilly and Company published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-232707), on May 20, 2026, and is solely responsible for the information contained therein.